Triumph Capital Management »

Jazz Pharmaceuticals shares owned by Triumph Capital Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Triumph Capital Management from 13F filings

Historical chart of Triumph Capital Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Triumph Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Triumph Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $481k 2.5k 189.05

More positions owned by Triumph Capital Management

Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Dimensional Etf Trust Short Duration F (DFSD)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p500 Etf (IVV)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Innovator Etfs Trust Quity Managd Flr (SFLR)
First Tr Exchange-traded A Com Shs (FEX)

View all positions for Triumph Capital Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Portfolio Management
Capital World Investors
Vanguard Capital Management
LSV Asset Management
Franklin Resources
Dimensional Fund Advisors
State Street Corporation
EcoR1 Capital
Bank of New York Mellon
Hanna Zanoni
Ameriprise Financial
Citadel Advisors
AQR Capital Management

View all funds holding Jazz Pharmaceuticals